Foresight to Initiate First Pilot Project for Its COVID-19 Symptom Detection Solution
July 17 2020 - 7:30AM
Business Wire
One of Israel’s largest health maintenance
organizations (HMO), Meuhedet, will use the system to screen up to
50,000 of its patients in the city of Ashdod
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an
innovator in automotive vision, announced today that it will begin
a pilot project for its prototype COVID-19 symptom detection mass
screening solution. The technology will be evaluated for several
months by Meuhedet, one of Israel’s largest health maintenance
organizations.
Meuhedet serves over one million patients from all sectors
across Israel and maintains more than 300 clinics throughout the
country. The pilot project will be carried out in Meuhedet’s
largest clinic in Ashdod which serves approximately 50,000
patients. To date, several entire neighborhoods in Ashdod have been
quarantined due to a large number of confirmed coronavirus
patients.
Foresight’s solution, which is based on the Company’s extensive
knowledge of thermal and visible-light cameras, artificial
intelligence and advanced algorithms, is designed to rapidly and
accurately detect some of the main symptoms associated with the
COVID-19 virus. The combination of several symptoms increases the
likelihood of accurate detection and potentially eliminates false
positive results.
The system will be installed, with no consideration to the
Company, at the entrance to the clinic, and will allow screening of
all incoming patients. Initial detection of high body temperature
will determine if further testing for fatigue and cough symptoms is
required. Real-time data collected by the system will allow
Foresight to further develop and improve the system, as more data
is collected.
“As the COVID-19 virus continues to spread, it is of great
concern to find a solution that will help to detect early symptoms
of the coronavirus and offer a solution aimed at preventing another
pandemic outbreak. This first pilot project with a leading Israeli
HMO validates the need for Foresight’s new screening solution in
high-traffic areas such as health clinics. Based on the large
number of Mehuedet clinics throughout Israel, a successful pilot
project may lead to further evaluation and future commercial
orders,” said Haim Siboni, CEO of Foresight.
About Foresight
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX),
founded in 2015, is a technology company engaged in the design,
development and commercialization of sensors systems for the
automotive industry. Through the Company’s wholly owned
subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd.,
Foresight develops both “in-line-of sight” vision systems and
“beyond-line-of-sight” cellular-based applications. Foresight’s
vision sensor is a four-camera system based on 3D video analysis,
advanced algorithms for image processing, and sensor fusion.
Eye-Net Mobile’s cellular-based application is a V2X
(vehicle-to-everything) accident prevention solution based on
real-time spatial analysis of clients’ movement.
The Company’s systems are designed to improve driving safety by
enabling highly accurate and reliable threat detection while
ensuring the lowest rates of false alerts. Foresight is targeting
the semi-autonomous and autonomous vehicle markets and predicts
that its systems will revolutionize automotive safety by providing
an automotive-grade, cost effective platform and advanced
technology.
For more information about Foresight and its wholly owned
subsidiary, Foresight Automotive, visit www.foresightauto.com,
follow @ForesightAuto1 on Twitter, or join Foresight Automotive on
LinkedIn.
Forward-Looking
Statements
This press release contains forward-looking statements within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995 and other Federal
securities laws. Words such as "expects," "anticipates," "intends,"
"plans," "believes," "seeks," "estimates" and similar expressions
or variations of such words are intended to identify
forward-looking statements. For example, Foresight is using
forward-looking statements in this press release when it discusses
creating a solution to detect symptoms of the coronavirus, that the
combination of several symptoms increases the likelihood of
accurate detection and potentially eliminates false positive
results, cooperation with Meuhedet for a pilot project, and that a
successful pilot project may lead to further evaluation and future
commercial orders. Because such statements deal with future events
and are based on Foresight’s current expectations, they are subject
to various risks and uncertainties, and actual results, performance
or achievements of Foresight could differ materially from those
described in or implied by the statements in this press
release.
In addition, Foresight cannot assure that any patent will issue
as a result of a pending patent application or, if issued, whether
it will issue in a form that will be advantageous to Foresight. The
forward-looking statements contained or implied in this press
release are subject to other risks and uncertainties, including
those discussed under the heading "Risk Factors" in Foresight's
annual report on Form 20-F filed with the Securities and Exchange
Commission ("SEC") on March 31, 2020, and in any subsequent filings
with the SEC. Except as otherwise required by law, Foresight
undertakes no obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events. References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release. Foresight is not
responsible for the contents of third-party websites.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200717005137/en/
Investor Relations Contact: Miri Segal-Scharia CEO MS-IR
LLC msegal@ms-ir.com 917-607-8654
Foresight Autonomous (NASDAQ:FRSX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Foresight Autonomous (NASDAQ:FRSX)
Historical Stock Chart
From Sep 2023 to Sep 2024